Published in Cancer Weekly, February 17th, 2009
"The migration of T cells was tracked in vivo using USE labeling. IL-2 in circulation was observed till day 15 with the levels reaching a peak by day 3. Significant activation of transferred T cells (CD69(+), CD25(+)) as well as significant increase in levels of NK cells (CD49b(+)) was seen in animals receiving IL-2," wrote A. Ambade and colleagues.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.